IP Library › Assignment 044632/0246
Patent Assignment
Reel/Frame 044632/0246

Assignment of Assignor's Interest

Recorded: 2018-01-16 Pages: 6
Assignor
MISSION THERAPEUTICS, INC.
Executed: 2018-01-12
Assignee
OPUS CRYSTAL HOLDINGS LIMITED
1007, CORNELL CENTRE, 50 WING TAI ROAD, CHAI WAN, HONG KONG, CHINA
Covered Properties (5)
Cancer Marker Protein and Peptides Thereof
Patent: 6,166,176 →
Application: 09/040,485 →
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 6,727,080 →
Application: 09/659,521 →
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 7,329,743 →
Application: 10/830,702 →
Publication: US 2005/0208508
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 7,635,759 →
Application: 12/029,113 →
Publication: US 2008/0249284
Gene Encoding Labyrinthin, a Marker for Cancer
Patent: 8,163,883 →
Application: 12/605,185 →
Publication: US 2010/0112582
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 9, 2000
From: RADOSEVICH, JAMES
To: IMMVARX, INC.
Reel/Frame 011124/0233 →
Assignment of Assignor's Interest Dec 4, 2000
From: RADOSEVICH, JAMES
To: IMMVARX, INC.
Reel/Frame 011359/0162 →
Confirmatory License Nov 13, 2003
From: RADOSEVICH, JAMES A.
To: DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 014675/0612 →
Assignment of Assignor's Interest Jun 10, 2008
From: RADOSEVICH, JAMES A.
To: IMMVARX, INC.
Reel/Frame 021074/0628 →
Assignment of Assignor's Interest Jul 27, 2011
From: RADOSEVICH, JAMES A.
To: MISSION THERAPEUTICS, INC.
Reel/Frame 026657/0136 →
Merger Jan 16, 2018
From: IMMVARX, INC.
To: MISSION THERAPEUTICS, INC.
Reel/Frame 044632/0113 →